51. 全身性強皮症 Scleroderma Clinical trials / Disease details
臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04986605 (ClinicalTrials.gov) | December 1, 2023 | 1/6/2021 | Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis | The Effectiveness of ECP in Diffuse Cutaneous Systemic Sclerosis | Diffuse Cutaneous Systemic Sclerosis | Device: Extracorporeal Photopheresis (ECP);Drug: UVADEX | Lawson Health Research Institute | Mallinckrodt | Not yet recruiting | 18 Years | N/A | All | 15 | Phase 2 | Canada |